Browse > Article
http://dx.doi.org/10.7231/JON.2011.22.2.129

Studies on the Behavioral Pharmacology of the Antidepressant Effect of Polygala japonica Houtt  

Lee, Eun-Kyung (Dept. of Oriental Neurospychiatry, College of Oriental Medicine, Daegu Haany University)
Chung, Dae-Kyoo (Dept. of Oriental Neurospychiatry, College of Oriental Medicine, Daegu Haany University)
Publication Information
Journal of Oriental Neuropsychiatry / v.22, no.2, 2011 , pp. 129-146 More about this Journal
Abstract
Objectives : The purpose of this study was to characterize the putative antidepressant and antianxiolytic effects of the 70% ethanol extract of Polygala japonica(EEPJ) using animal's behavioral experiment in mice. Methods : The effect of EEPJ on the anxioty and depressive disorder was investigated via mice's behavioral experiment like Elevated plus-maze, Horizontal wire test, Open field test, Forced swimming test, Tail suspension test, and it was happen via any mechanism by WAY 100635, a 5-HT1A receptor antagonist and by Flumazenil, a GABAA antagonist Results : 1. In the EPM, single treatments of the EEPJ(200 and 400mg/kg) had usefully antianxiolytic effects versus vehicle, which was medicated via the serotonergic nervous system. 2. In the HWT, single treatments of the EEPJ were no changes in the myorelaxant effects versus vehicle. 3. In the OFT, single treatments of the EEPJ were no changes in the locomotor activity versus vehicle. 4. In the FST, single treatments of the EEPJ(50mg/kg) significantly reduced the immobility time versus vehicle. 5. In the TST, single treatments of the EEPJ(50mg/kg) significantly reduced the immobility time versus vehicle. Conclusions : These results indicate that EEPJ is an effective antidepressant and antianxiolytic activity in mice, and it might be usefully applied for prevention and treatment of depressive disorder through evolutive study like development of various experimental models.
Keywords
Polygala japonica; Anxiolytic; Antidepressant; Elevated plus-maze; Forced swimming test;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 홍성유, 박선동. 시호가 우울증 모델 백서의 catecholamine에 미치는 영향. 대한본초학회지. 2003;18(4):235-53.
2 이인. 녹용의 항우울효과에 관한 실험적 연구. 동국대학교 대학원. 2004.
3 이진우. 연자육의 항우울 효과 및 프로티움 분석을 통한 기전 연구. 경희대학교 대학원. 2004.
4 김용구. 우울증의 신경생물학. 대한의사협회지. 2003;9:783-93.
5 Zhang ZJ. Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci. 2004;75(14):1659-9.   DOI   ScienceOn
6 Butler SG, Meegan MJ. Recent developments in the design of anti-depressive therapies; targeting the serotonin transporter. Curr Med Chem. 2008;15(17):1737-61.   DOI   ScienceOn
7 Beaubrun G, Gray GE. A review of herbal medicines for psychiatric disorders. Psychiatr Serv. 2000;51(9):1130-4.   DOI   ScienceOn
8 홍원식 編. 精交黃帝內經素問. 서울:동양의학연구원. 1981:277, 282, 288-9, 303.
9 張介賓. 景岳全書. 서울:행림서원. 1975:411-7, 841-2.
10 이태희. 오수유 분획물의 항우울증 효과에 대한 연구. 대한본초학회지. 1998;13(1):139-45.
11 김인재, 이동원. 인삼과 향부자의 항우울효과에 관한 실험적 연구. 동의신경정신과학회지. 2004;15(1):101-19.
12 임숭만. 흰쥐에 대한 보혈안신탕의 실험적 연구. 경희대학교 대학원. 2001.
13 오세관. 신경전달물질과 뇌질환. 서울:신일상사. 2005:297-344.
14 대한신경정신의학회 편. 신경정신과학. 서울:하나의학사. 1998:351-6.
15 Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry. 1997;54(7):597-606.   DOI   ScienceOn
16 전국한의과대학 신경정신과 교과서편찬위원회 편. 한의신경정신 과학. 서울:집문당. 2007:256-65, 472-86, 493-502.
17 장미경. 수삼추출물 투여 및 향기흡입이 항우울작용에 미치는 영향에 관한 연구. 동국대학교 대학원. 2003.
18 이덕기. 구기자의 항우울효과 및 serotonin에 미치는 영향. 동국대학교 대학원. 2004.
19 Soo-Jeong Kim. Antidepressant-like effects of Lycium chinense Mill. and betaine in an animal model of depression. Graduate school of East-West Medical Science. Kyung Hee University. 2005.
20 이승기, 김종우, 황의완, 김현택, 곽소영, 박은혜. 분심기음의 우울증 모델 흰쥐에 대한 실험적 연구. 대한한의학회지. 2001;22(3):129-40.
21 박종흠. 천왕보심단의 항우울효과 및 monoamine 대사에 미치는 영향. 동국대학교 대학원. 2004.
22 김창민, 신민교, 안덕균, 이경순 역. 중약대사전. 서울:도서출판 정담. 1998:424-7.
23 한윤승. 수비전 추출물의 항우울효과에 관한 연구. 동국대학교 대학원. 2004.
24 김정기. 칠복음의 항우울에 대한 실험적 연구. 동국대학교 대학원. 2005.
25 김정기. 삼정환의 항우울에 대한 실험적 연구. 동국대학교 대학원. 2005.
26 吳其溶選. 植物名實圖考. 北京:世界書局印行. 1987:383.
27 中華本草委員會. 中華本草 5권. 上海:上海科學技術出版社. 1999:57.
28 Handley SR and Tricklebank MD. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol. 1995;327:1-5.
29 이정아, 김종우, 황의완, 곽소영, 김민정, 박은혜. Chronic Mild Stress로 유발된 우울증 모델 흰쥐에 대한 歸脾湯의 실험적 연구. 동의신경정신과학회지. 2001;12(1):123-36.
30 조충훈. 귀비온담탕의 CMS로 유발된 우울증 모델 흰쥐에 대한 실험적 연구. 경희대학교 대학원. 2000.
31 Overstreet DH, Pucilowski O, Rezvani AH, Janowsky DS. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology(Berl). 1995;121(1):27-37.   DOI
32 Brugger AJ, Brugger-Frigols I, Conesa P. Difficulties of animal experiments in psychopharmacology. Punctual aspects of antidepressants. Rev Esp Fisiol. 1989;45:245-54.
33 Petit-Demouliere B, Chenu F, Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology(Berl). 2005;177(3):245-55.   DOI   ScienceOn
34 Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology(Berl). 1985;85(3):367-70.   DOI
35 Pellow S, Chopin P, File SE, Briley M. Validation of open-closed arm entries in an Elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14:149-67.   DOI   ScienceOn
36 Bonetti EP, Pieri L, Cumin R, Schaffner R, Pieri M, Gamzu ER, Muller RKM, Haefely W. Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology(Berl). 1982;78:8-18.   DOI
37 Porsolt RD. Animal model of depression. Biomedicine. 1979;30(3):139-40.
38 이근후. 정신장애의 진단 및 통계편람 제4판 (DSM-IV). 서울:하나출판사. 1995:419-33.
39 Teste JF, Pelsy-Johann I, Decelle T, Boulu RG. Anti-immobility activity of different antidepressant drugs using the tail suspension test in normal or reserpinized mice. Fundam Clin Pharmacol. 1993;7(5):219-26.   DOI   ScienceOn
40 이정균 정신의학. 서울:일조각. 1994:212-55.
41 Pollack MH. Comorbid anxiety and depression. J Clin Psychiatry. 2005;66(8):22-9.
42 Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7(3):249-64.
43 Masand PS, Gupta S. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine. Ann Clin Psychiatry. 2002;14(3):175-82.   DOI   ScienceOn
44 Sheehan DV, Sheehan KH. Current approaches to the pharmacologic treatment of anxiety disorders. Psychopharmacol Bull. 2007;40(1):98-109.
45 虞搏. 醫學正傳. 서울:대성출판사. 1982:515-27.
46 황의완, 김지혁. 동의정신의학. 서울:현대의학서적사. 1992:608-11.
47 趙尙華. 張子琳醫療經驗選輯. 山西:山西人民出版社. 1986:88-91.
48 李輝東, 周秀芬. 中醫精神科 臨證備要. 北京:中醫古籍出版社. 1996:108-9.
49 정보섭, 신민교. 도해 향약(생약)대사전(약용식물편). 서울:영림사. 1995:798-9.
50 Kou J, Si M, Dai G, Lin Y, Zhu D. Antiinflammatory activity of Polygala japonica extract. Fitoterapia. 2006;77(6):411-5.   DOI   ScienceOn
51 Li TZ, Zhang WD, Yang GJ, Liu WY, Chen HS, Shen YH. Saponins from Polygala japonica and their effects on a forced swimming test in mice. J Nat Prod. 2006;69(4):591-4.   DOI   ScienceOn
52 Gladney M, Stanley RT, Hendricks SE. Anxiolytic activity of chloral hydrate and hydroxyzine. Pediatr Dent. 1994;16(3):183-9.
53 Wang H, Gao J, Kou J, Zhu D, Yu B. Anti-inflammatory activities of triterpenoid saponins from Polygala japonica. Phytomedicine. 2008;15(5):321-6.   DOI   ScienceOn
54 조은환, 서영배, 노성수. 과자금 추출물과 Cyclosporin A가 OVA로 천식이 유발된 생쥐의염증성 면역세포에 미치는 영향. 대한본초학회지. 2008;23(2):87-97.
55 Zhang D, Miyase T, Kuroyanagi M, Umehara K, Ueno A. Studies on the constituents of Polygala japonica Houtt. I. Structures of polygalasaponins I-X. Chem Pharm Bull. 1995;43(1):115-20.   DOI   ScienceOn
56 Zhang D, Miyase T, Kuroyanagi M, Umehara K, Ueno A. Studies on the constituents of Polygala japonica Houtt. II. Structures of polygalasaponins XI-XIX. Chem Pharm Bull. 1995;43(6):966-70.   DOI   ScienceOn
57 Imaizumi M, Onodera K. Animal models of anxiety. Nippon Yakurigaku Zasshi. 2000;115(1):5-12.   DOI   ScienceOn
58 Kent JM, Mathew SJ and Gorman JM. Molecular Targets in the Treatment of Anxiety. Society of Biological Psychiatry. 2002;52:1008-30.   DOI   ScienceOn
59 Uhlenhuth EH. Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic. J Clin Psychiatry. 1982;43(12):109-16.
60 Chouinard G, Lefko-Singh K, Teboul E. Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem. Cell Mol Neurobiol. 1999;19(4):533-52.   DOI   ScienceOn
61 Boyce P, Judd F. The place for the tricyclic antidepressants in the treatment of depression. Aust N Z J Psychiatry. 1999;33(3):323-7.   DOI   ScienceOn
62 Bymaster FP, McNamara RK, Tran PV. New approaches to developing antidepressants by enhancing monoaminergic neurotransmission. Expert Opin Investig Drugs. 2003;12(4):531-43.   DOI   ScienceOn
63 Segrave R, Nathan PJ. Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression. Hum Psychopharmacol. 2005;20(3):163-74.   DOI   ScienceOn
64 Cowen PJ. A role for 5-HT in the action of antidepressant drugs. Pharmacol Ther. 1990;46(1):43-51.   DOI   ScienceOn
65 Harvey RA, Champe MJ, Mycek MJ. Lippincott's Illustrated Reviews Pharmacology, 2nd edition. Philadelphia:Lippincott Williams ＆ Wilkins. 2000:89-93, 119-26.
66 Moret C, Grimaldi B, Massot O, Fillion G. The role and therapeutic potential of 5-HT-moduline in psychiatry. Semin Clin Neuropsychiatry. 2003;8(2):137-46.   DOI   ScienceOn
67 Gorman JM. New molecular targets for antianxiety interventions. Clin Psychiatry. 2003;64(3):28-35.
68 Leung JW, Xue H. GABAergic functions and depression: from classical therapies to herbal medicine. Curr Drug Targets CNS Neurol Disord. 2003;2(6):363-74.   DOI   ScienceOn